Report Detail

Request for Sample of this report

Pharma & Healthcare Global Oral Anorexiant Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4769750
    • |
  • 06 November, 2026
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Anorexiant Drug market size was valued at US$ 850 million in 2025 and is forecast to a readjusted size of US$ 1261 million by 2032 with a CAGR of 5.9% during review period.
Oral anorexiant drugs are medications designed to suppress appetite and reduce food intake, aiding in weight loss for individuals who are overweight or obese. These drugs typically act on the central nervous system, either by stimulating the release of certain neurotransmitters like norepinephrine and dopamine, which can create a feeling of fullness, or by blocking the reuptake of these chemicals, prolonging their appetite-suppressing effects. Commonly prescribed oral anorexiants include phentermine, diethylpropion, and lorcaserin. They are often used in conjunction with lifestyle modifications such as diet and exercise to enhance weight loss results. However, these medications can have side effects such as increased heart rate, elevated blood pressure, insomnia, and potential for abuse or dependency, and they are usually recommended for short-term use under medical supervision.
This report is a detailed and comprehensive analysis for global Oral Anorexiant Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Anorexiant Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anorexiant Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anorexiant Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anorexiant Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Anorexiant Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Anorexiant Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akrimax Pharmaceuticals, Janssen Ortho, Roche Pharmaceuticals, Teva Pharmaceuticals, Arena Pharmaceuticals, Abbott Pharmaceuticals, Epic Pharma, Novo Nordisk, Patheon Pharmaceuticals, Recordati Rare Diseases, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Anorexiant Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Catecholamines
Serotonin
Market segment by Application
Hospitals
Clinics
Retail Sales
Online Pharmacies
Other
Major players covered
Akrimax Pharmaceuticals
Janssen Ortho
Roche Pharmaceuticals
Teva Pharmaceuticals
Arena Pharmaceuticals
Abbott Pharmaceuticals
Epic Pharma
Novo Nordisk
Patheon Pharmaceuticals
Recordati Rare Diseases
Catalent Pharma Solutions
MOVA Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anorexiant Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Anorexiant Drug, with price, sales quantity, revenue, and global market share of Oral Anorexiant Drug from 2021 to 2026.
Chapter 3, the Oral Anorexiant Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anorexiant Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Anorexiant Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Anorexiant Drug.
Chapter 14 and 15, to describe Oral Anorexiant Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Anorexiant Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Catecholamines
    • 1.3.3 Serotonin
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Anorexiant Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Retail Sales
    • 1.4.5 Online Pharmacies
    • 1.4.6 Other
  • 1.5 Global Oral Anorexiant Drug Market Size & Forecast
    • 1.5.1 Global Oral Anorexiant Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Oral Anorexiant Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Oral Anorexiant Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Akrimax Pharmaceuticals
    • 2.1.1 Akrimax Pharmaceuticals Details
    • 2.1.2 Akrimax Pharmaceuticals Major Business
    • 2.1.3 Akrimax Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.1.4 Akrimax Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Akrimax Pharmaceuticals Recent Developments/Updates
  • 2.2 Janssen Ortho
    • 2.2.1 Janssen Ortho Details
    • 2.2.2 Janssen Ortho Major Business
    • 2.2.3 Janssen Ortho Oral Anorexiant Drug Product and Services
    • 2.2.4 Janssen Ortho Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Janssen Ortho Recent Developments/Updates
  • 2.3 Roche Pharmaceuticals
    • 2.3.1 Roche Pharmaceuticals Details
    • 2.3.2 Roche Pharmaceuticals Major Business
    • 2.3.3 Roche Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.3.4 Roche Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Roche Pharmaceuticals Recent Developments/Updates
  • 2.4 Teva Pharmaceuticals
    • 2.4.1 Teva Pharmaceuticals Details
    • 2.4.2 Teva Pharmaceuticals Major Business
    • 2.4.3 Teva Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.4.4 Teva Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.5 Arena Pharmaceuticals
    • 2.5.1 Arena Pharmaceuticals Details
    • 2.5.2 Arena Pharmaceuticals Major Business
    • 2.5.3 Arena Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.5.4 Arena Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Arena Pharmaceuticals Recent Developments/Updates
  • 2.6 Abbott Pharmaceuticals
    • 2.6.1 Abbott Pharmaceuticals Details
    • 2.6.2 Abbott Pharmaceuticals Major Business
    • 2.6.3 Abbott Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.6.4 Abbott Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Abbott Pharmaceuticals Recent Developments/Updates
  • 2.7 Epic Pharma
    • 2.7.1 Epic Pharma Details
    • 2.7.2 Epic Pharma Major Business
    • 2.7.3 Epic Pharma Oral Anorexiant Drug Product and Services
    • 2.7.4 Epic Pharma Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Epic Pharma Recent Developments/Updates
  • 2.8 Novo Nordisk
    • 2.8.1 Novo Nordisk Details
    • 2.8.2 Novo Nordisk Major Business
    • 2.8.3 Novo Nordisk Oral Anorexiant Drug Product and Services
    • 2.8.4 Novo Nordisk Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Novo Nordisk Recent Developments/Updates
  • 2.9 Patheon Pharmaceuticals
    • 2.9.1 Patheon Pharmaceuticals Details
    • 2.9.2 Patheon Pharmaceuticals Major Business
    • 2.9.3 Patheon Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.9.4 Patheon Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Patheon Pharmaceuticals Recent Developments/Updates
  • 2.10 Recordati Rare Diseases
    • 2.10.1 Recordati Rare Diseases Details
    • 2.10.2 Recordati Rare Diseases Major Business
    • 2.10.3 Recordati Rare Diseases Oral Anorexiant Drug Product and Services
    • 2.10.4 Recordati Rare Diseases Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Recordati Rare Diseases Recent Developments/Updates
  • 2.11 Catalent Pharma Solutions
    • 2.11.1 Catalent Pharma Solutions Details
    • 2.11.2 Catalent Pharma Solutions Major Business
    • 2.11.3 Catalent Pharma Solutions Oral Anorexiant Drug Product and Services
    • 2.11.4 Catalent Pharma Solutions Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Catalent Pharma Solutions Recent Developments/Updates
  • 2.12 MOVA Pharmaceuticals
    • 2.12.1 MOVA Pharmaceuticals Details
    • 2.12.2 MOVA Pharmaceuticals Major Business
    • 2.12.3 MOVA Pharmaceuticals Oral Anorexiant Drug Product and Services
    • 2.12.4 MOVA Pharmaceuticals Oral Anorexiant Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 MOVA Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Oral Anorexiant Drug by Manufacturer

  • 3.1 Global Oral Anorexiant Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oral Anorexiant Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oral Anorexiant Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oral Anorexiant Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oral Anorexiant Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oral Anorexiant Drug Manufacturer Market Share in 2025
  • 3.5 Oral Anorexiant Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Anorexiant Drug Market: Region Footprint
    • 3.5.2 Oral Anorexiant Drug Market: Company Product Type Footprint
    • 3.5.3 Oral Anorexiant Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Anorexiant Drug Market Size by Region
    • 4.1.1 Global Oral Anorexiant Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oral Anorexiant Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oral Anorexiant Drug Average Price by Region (2021-2032)
  • 4.2 North America Oral Anorexiant Drug Consumption Value (2021-2032)
  • 4.3 Europe Oral Anorexiant Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oral Anorexiant Drug Consumption Value (2021-2032)
  • 4.5 South America Oral Anorexiant Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oral Anorexiant Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Oral Anorexiant Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Oral Anorexiant Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Oral Anorexiant Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Oral Anorexiant Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Oral Anorexiant Drug Market Size by Country
    • 7.3.1 North America Oral Anorexiant Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oral Anorexiant Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oral Anorexiant Drug Market Size by Country
    • 8.3.1 Europe Oral Anorexiant Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oral Anorexiant Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oral Anorexiant Drug Market Size by Region
    • 9.3.1 Asia-Pacific Oral Anorexiant Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oral Anorexiant Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Oral Anorexiant Drug Market Size by Country
    • 10.3.1 South America Oral Anorexiant Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oral Anorexiant Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Anorexiant Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oral Anorexiant Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oral Anorexiant Drug Market Size by Country
    • 11.3.1 Middle East & Africa Oral Anorexiant Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oral Anorexiant Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oral Anorexiant Drug Market Drivers
  • 12.2 Oral Anorexiant Drug Market Restraints
  • 12.3 Oral Anorexiant Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Anorexiant Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Anorexiant Drug
  • 13.3 Oral Anorexiant Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Anorexiant Drug Typical Distributors
  • 14.3 Oral Anorexiant Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oral Anorexiant Drug. Industry analysis & Market Report on Oral Anorexiant Drug is a syndicated market report, published as Global Oral Anorexiant Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Oral Anorexiant Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo